Microvision Inc (MVIS)

[Slojab]

From the Supplement posted AHs.

USE OF PROCEEDS

We estimate that the net proceeds to us from this offering will be approximately $9.2 million (or approximately $10.6 million if the underwriter’s over-allotment option is exercised in full), in each case after deducting the underwriting discount and estimated offering expenses payable by us. We anticipate that the net proceeds from the sale of the securities offered under this prospectus supplement will be used for general corporate purposes, which may include, but are not limited to, working capital and capital expenditures. Pending the application of the net proceeds, we expect to invest the proceeds in investment-grade, interest-bearing instruments or other securities